Miner Company
FDA shuffles top drug, biologics leaders in latest shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC. The shake up caps a tumultuous week at the FDA.
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC. The shake up caps a tumultuous week at the FDA.